Exagen Inc. Soared
Exagen Inc. (XGN:NASDAQ) rocketted at $3.98, representing a gain of 34.9%. On Mon, May 11, 2026, XGN:NASDAQ hit a New 2-Week High of $3.98. The stock got featured on our News Catalysts scanner on Mon, May 11, 2026 at 02:03 PM in the 'MISCELLANEOUS' category. From Mon, Apr 27, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days
About Exagen Inc. (XGN:NASDAQ)
Exagen Diagnostics Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.
Top 10 Gainers:
- WORK Medical Technology Group LTD (WOK:NASDAQ), 206.25%
- POMDOCTOR LIMITED (POM:NASDAQ), 97.47%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 50%
- Jiuzi Holdings, Inc. (JZXN:NASDAQ), 48.07%
- Everspin Technologies, Inc. (MRAM:NASDAQ), 47.68%
- Peraso Inc. (PRSO:NASDAQ), 39.2%
- GSI Technology, Inc. (GSIT:NASDAQ), 38.7%
- Exagen Inc. (XGN:NASDAQ), 34.92%
- Beazer Homes USA, Inc. (BZH:NYSE), 34.04%
- J-Star Holding Co. Ltd. (YMAT:NASDAQ), 33.16%